Ministers planning drug pricing shake-up to stem pharma exodus October 8, 2025 Ministers are drawing up a radical overhaul of NHS spending rules in a bid to shore up the UK’s world-leading life sciences industry after a string of pharma giants cancelled major UK investment projects. In what would amount to one of the largest shake-ups of NHS drug purchasing rules in recent history, the Prime Minister [...]
GSK shares rally as chief Emma Walmsley to exit after eight years September 29, 2025 The chief executive of pharmaceutical giant GSK has announced plans to step down from the company at the end of the year. Emma Walmsley, who took the helm of the drugmaker in 2017, will be replaced by chief commercial officer Luke Miels. Miels – the former Executive Vice President of Astrazeneca – also joined the [...]
GSK plots $30bn investment into US in latest blow to UK’s pharma sector September 17, 2025 GSK has unveiled a new plan to spend $30bn (£22bn) on research and manufacturing facilities in the US. The London-based business said the capital would be deployed over the next five years and would create hundreds of high-skilled American jobs in areas such as AI and advanced digital technologies. The investment of £4.4bn per year [...]
Spotlight turns to FTSE 100 clients of Peter Mandelson’s advisory firm after government sacking September 12, 2025 After Peter Mandelson’s dramatic ousting from government over his close relationship with paedophile Jeffrey Epstein, the firms that chose to partner with his consultancy Global Counsel have come under the spotlight. More than two dozen major corporations hired Global Counsel to conduct lobbying services over the past two years, disclosures from the Office of the [...]
Trump tariffs: FTSE 100 holds steady as pharma and metals brace for levies July 9, 2025 The FTSE 100 opened 22 points up this morning, despite threats of pharma and metals tariffs with stark implications for major stocks on the blue chip index. President Trump has said that an announcement is coming “very soon” on pharmaceutical tariffs – with a possible 200 per cent rate landing in “about a year”. Major [...]
GSK and Astrazeneca shares slump as Trump vows drug price cut May 12, 2025 GSK and Astrazeneca shares fall as Trump announces drug price cuts in a new executive order.
FTSE 100’s record run ends as pharma stocks slide on new Trump appointment May 7, 2025 The FTSE 100’s record run came to an end on Wednesday as pharma stocks slumped on the back of a controversial US regulatory appointment. The blue-chip index spent the entire session in the red and closed off 0.4 per cent. Drugmakers GSK and Astrazeneca were among the top fallers, at nearly five per cent and [...]
GSK shares rise as FTSE 100 giant ‘well positioned’ for pharma tariffs April 30, 2025 British drugmaker GSK insisted it was “well positioned” to respond to the impact of sector-specific tariffs amid widespread speculation President Donald Trump is set to target pharmaceutical imports with his tariff agenda. Trump voiced his desire to slap tariffs on pharma products in the “not too distant future”. He previously said: “We don’t make our [...]
As FTSE 100 pharma firms wait for a tariffs decision, what would drugs levies mean for consumers? April 22, 2025 For FTSE 100 businesses navigating the shifting sands of Trump’s trade war, the uncertainty surrounding the tariffs has been almost as painful as the stock market shocks. The pharmaceutical industry has been left in a particularly agonising limbo: free, for now, from the 10 per cent baseline import tax, but the US President keeps making [...]
Government scrambles to swerve Trump pharma tariffs April 16, 2025 A race against time is underway to shield the UK pharmaceutical sector from potentially swinging Trump tariffs on imported drugs. As it stands, there is an exemption for pharmaceuticals on the baseline 10 per cent tariffs for goods coming into the US. However, President Trump has warned that there will be tariffs on imported pharma [...]